Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Hemoglobin A1c Reduction With the GLP-1 Receptor Agonist Semaglutide Is Independent of Baseline eGFR: post hoc Analysis of the SUSTAIN and PIONEER Programs
PaperCitations, authors & open-access status
Hemoglobin A1c Reduction With the GLP-1 Receptor Agonist Semaglutide Is Independent of Baseline eGFR: post hoc Analysis of the SUSTAIN and PIONEER Programs is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 36 citations, 2022 year and gold oa status.
36
Citations
2022
Year
gold
OA Status